Prolonged sporadic hemiplegic migraine associated with a novel de novo missense ATP1A2 gene mutation

Headache. 2011 Mar;51(3):447-450. doi: 10.1111/j.1526-4610.2010.01793.x. Epub 2010 Nov 4.

Abstract

Hemiplegic migraine is a rare form of migraine characterized by periodic attacks of migraine with neurologic aura and transient hemiplegia. There are familial and sporadic cases, both on a genetic basis; we describe the case of a 6-year-old boy affected by sporadic hemiplegic migraine, showing a novel ATP1A2 gene missense mutation (p.Gly715Arg) in exon 16. Long-term treatment with flunarizine resulted in good clinical response and prevention of further attacks.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / therapeutic use
  • Child
  • Flunarizine / therapeutic use
  • Hemiplegia / genetics*
  • Humans
  • Migraine with Aura / diagnosis
  • Migraine with Aura / drug therapy
  • Migraine with Aura / genetics*
  • Mutation, Missense / genetics*
  • Sodium-Potassium-Exchanging ATPase / genetics*
  • Treatment Outcome

Substances

  • Anticonvulsants
  • ATP1A2 protein, human
  • Sodium-Potassium-Exchanging ATPase
  • Flunarizine